| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 15 | |
| #2 | China | 14 | |
| #3 | United States | 13 | |
| #4 | EPO (European Patent Office) | 10 | |
| #5 | United Kingdom | 5 | |
| #6 | Canada | 4 | |
| #7 | Republic of Korea | 4 | |
| #8 | Singapore | 4 | |
| #9 | Taiwan | 3 | |
| #10 | Colombia | 2 | |
| #11 | Costa Rica | 2 | |
| #12 | Israel | 2 | |
| #13 | Australia | 1 | |
| #14 | Peru | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Salimu Josephine | 73 |
| #2 | Moulder Kevin | 73 |
| #3 | Goubier Anne | 73 |
| #4 | Merchiers Pascal | 73 |
| #5 | Quezada Sergio | 63 |
| #6 | Goyenechea Corzo Beatriz | 60 |
| #7 | Prinz Bianka | 43 |
| #8 | Geoghegan James | 34 |
| #9 | Brown Mark | 34 |
| #10 | Goyenechea Beatriz | 13 |
| Publication | Filing date | Title |
|---|---|---|
| IL276997D0 | Anti-cd25 for tumour specific cell depletion | |
| SG11202008699WA | Anti-cd25 for tumour specific cell depletion | |
| EP3649153A1 | Compounds and methods for tumour-specific cell depletion | |
| GB201804028D0 | Anti-CD25 antibody agents | |
| GB201804029D0 | Anti-CD25 antibody agents | |
| GB201804027D0 | Anti-CD25 antibody agents | |
| US2020010554A1 | Fc-optimized anti-cd25 for tumor specific cell depletion | |
| GB201714429D0 | Compounds and methods for tumour-specific cell depletion | |
| GB201710879D0 | Methods and compounds for tumour-specific cell depletion |